SC
PODD icon

Scholtz & Company’s Insulet PODD Stock Holding History

Scholtz & Company’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,164
Closed -$3.18M – 56
2026
Q1 		$3.18M Buy
15,164
+2,188
+17% +$550K 1.63% 28
2025
Q4 		$3.69M Buy
12,976
+1,718
+15% +$537K 1.6% 26
2025
Q3 		$3.48M Buy
11,258
+1,912
+20% +$599K 1.53% 25
2025
Q2 		$2.94M Sell
9,346
-6
-0.1% -$1.73K 1.29% 30
2025
Q1 		$2.46M Buy
9,352
+272
+3% +$73.6K 1.22% 27
2024
Q4 		$2.37M Buy
9,080
+669
+8% +$168K 1.13% 28
2024
Q3 		$1.96M Sell
8,411
-740
-8% -$152K 0.92% 30
2024
Q2 		$1.85M Buy
+9,151
New +$1.65M 0.79% 30

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Scholtz & Company's PODD Position: Q2 2026 in Review

Scholtz & Company sold out of Insulet (PODD) in Q2 2026, closing a stake of 15,164 shares — an estimated $3.18M sold.

Scholtz & Company first reported a position in PODD in Q2 2024 and held it in 8 quarters. The position peaked at $3.69M in Q4 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Scholtz & Company reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • Scholtz & Company sold 15,164 Insulet shares in Q2 2026, an estimated $3.18M.
  • Scholtz & Company first reported a position in Insulet in Q2 2024 and held it in 8 quarters.
  • Scholtz & Company's Insulet position peaked at $3.69M in Q4 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Scholtz & Company's 13F filing for Q2 2026, filed 11 Aug 2026.